Traws Pharma (TRAW) Short Interest Ratio & Short Volume $2.40 -0.17 (-6.61%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$2.42 +0.02 (+0.63%) As of 03/28/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Traws Pharma Short Interest DataTraws Pharma (TRAW) has a short interest of 76,300 shares, representing 2.08% of the float (the number of shares available for trading by the public). This marks a -55.72% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 156,377 shares to cover all short positions.Current Short Interest76,300 sharesPrevious Short Interest172,300 sharesChange Vs. Previous Month-55.72%Dollar Volume Sold Short$209,062.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares3,651,000 sharesFloat Size3,670,000 sharesShort Percent of Float2.08%Today's Trading Volume26,593 sharesAverage Trading Volume156,377 sharesToday's Volume Vs. Average17% Short Selling Traws Pharma? Sign up to receive the latest short interest report for Traws Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRAW Short Interest Over TimeTRAW Days to Cover Over TimeTRAW Percentage of Float Shorted Over Time Remove Ads Traws Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202576,300 shares $209,062.00 -55.7%2.1%0.1 $2.74 2/28/2025172,300 shares $570,313.00 -36.2%6.5%0.3 $3.31 2/15/2025270,200 shares $1.68 million +79.2%10.2%0.5 $6.21 1/31/2025150,800 shares $1.10 million -12.3%5.8%0.3 $7.28 1/15/2025171,900 shares $1.18 million +21.1%6.7%0.3 $6.86 12/31/2024141,900 shares $1.26 million +1,956.5%5.2%0.3 $8.88 12/15/20246,900 shares $32,085.69 -10.4%0.3%0 $4.65 11/30/20247,700 shares $35,266.00 -26.0%0.3%0.7 $4.58 11/15/202410,400 shares $51,896.00 +40.5%0.5%0.9 $4.99 10/31/20247,400 shares $37,296.00 -23.7%0.3%0.7 $5.04 10/15/20249,700 shares $46,560.00 -24.2%0.3%1.1 $4.80 9/30/202412,800 shares $75,264.00 +652.9%0.6%1.6 $5.88 9/15/20241,700 shares $594.49 -92.7%N/A0.3 $0.35 8/31/202423,400 shares $8,669.70 +2.6%0.1%0.3 $0.37 8/15/202422,800 shares $8,208.00 +40.7%0.1%0.2 $0.36 7/31/202416,200 shares $6,416.82 -60.7%0.1%0.2 $0.40 7/15/202441,200 shares $17,711.88 No Change0.2%0.4 $0.43 TRAW Short Interest - Frequently Asked Questions What is Traws Pharma's current short interest? Short interest is the volume of Traws Pharma shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 76,300 shares of TRAW short. 2.08% of Traws Pharma's shares are currently sold short. Learn More on Traws Pharma's current short interest. Which institutional investors are shorting Traws Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Traws Pharma: Group One Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Traws Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.08% of Traws Pharma's floating shares are currently sold short. Is Traws Pharma's short interest increasing or decreasing? Traws Pharma saw a decrease in short interest in March. As of March 15th, there was short interest totaling 76,300 shares, a decrease of 55.7% from the previous total of 172,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Traws Pharma's float size? Traws Pharma currently has issued a total of 3,651,000 shares. Some of Traws Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Traws Pharma currently has a public float of 3,670,000 shares. How does Traws Pharma's short interest compare to its competitors? 2.08% of Traws Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Traws Pharma: Barinthus Biotherapeutics plc (0.04%), Lantern Pharma Inc. (2.98%), Xilio Therapeutics, Inc. (3.47%), Atara Biotherapeutics, Inc. (19.03%), SCYNEXIS, Inc. (1.89%), Dyadic International, Inc. (0.47%), FibroBiologics, Inc. (7.83%), Prelude Therapeutics Incorporated (6.35%), Surrozen, Inc. (6.12%), Akari Therapeutics, Plc (0.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Traws Pharma stock? Short selling TRAW is an investing strategy that aims to generate trading profit from Traws Pharma as its price is falling. TRAW shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Traws Pharma? A short squeeze for Traws Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRAW, which in turn drives the price of the stock up even further. How often is Traws Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRAW, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies BRNS Short Interest LTRN Short Interest XLO Short Interest ATRA Short Interest SCYX Short Interest DYAI Short Interest FBLG Short Interest PRLD Short Interest SRZN Short Interest AKTX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRAW) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.